眼科深度学习:技术与临床考量
本文综述人工智能与深度学习在眼科的应用,涵盖糖尿病视网膜病变、青光眼、年龄相关性黄斑变性、早产儿视网膜病变、屈光不正及心血管风险因素识别,并讨论构建深度学习系统的技术层面、临床转化挑战及全球眼病负担与未满足需求。
要点
- 深度学习系统在检测糖尿病视网膜病变、青光眼、年龄相关性黄斑变性和早产儿视网膜病变等方面表现准确有效。
- 利用光学相干断层扫描图像识别新生血管性年龄相关性黄斑变性和糖尿病黄斑水肿的疾病特征、进展和治疗反应受到关注。
- 将机器学习应用于视野检查可能有助于检测青光眼进展。
核心结论
- 人工智能、机器学习和深度学习可能在临床眼科实践中发挥关键作用,对全球老龄化背景下主要致盲原因的筛查、诊断和随访具有意义。
研究设计与样本
- 本文为综述,描述全球眼病负担、未满足需求及人工智能和深度学习系统可能适用的公共卫生重要常见疾病,并讨论构建深度学习系统的技术与临床层面及临床应用的潜在挑战。
主要发现
- 包括预注册前瞻性临床试验在内的新研究表明,深度学习系统从数字眼底照片中检测糖尿病视网膜病变、青光眼、年龄相关性黄斑变性、早产儿视网膜病变、屈光不正及识别心血管风险因素和疾病是准确有效的。
- 利用光学相干断层扫描图像识别新生血管性年龄相关性黄斑变性和糖尿病黄斑水肿等视网膜疾病的疾病特征、进展和治疗反应方面,人工智能和深度学习系统的应用日益受到关注。
- 将机器学习应用于视野检查可能有助于检测青光眼进展。
- 将包括电子健康记录在内的临床数据纳入人工智能和深度学习算法的研究有限,且尚无前瞻性研究证明人工智能和深度学习算法能够预测临床眼病的发生。
局限性
- 将包括电子健康记录在内的临床数据纳入人工智能和深度学习算法的研究有限。
- 尚无前瞻性研究证明人工智能和深度学习算法能够预测临床眼病的发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The advent of computer graphic processing units, improvement in mathematical models and availability of big data has allowed artificial intelligence (AI) using machine learning (ML) and deep learning (DL) techniques to achieve robust performance for broad applications in social-media, the internet of things, the automotive industry and healthcare. DL systems in particular provide improved capability in image, speech and motion recognition as well as in natural language processing. In medicine, significant progress of AI and DL systems has been demonstrated in image-centric specialties such as radiology, dermatology, pathology and ophthalmology. New studies, including pre-registered prospective clinical trials, have shown DL systems are accurate and effective in detecting diabetic retinopathy (DR), glaucoma, age-related macular degeneration (AMD), retinopathy of prematurity, refractive error and in identifying cardiovascular risk factors and diseases, from digital fundus photographs. There is also increasing attention on the use of AI and DL systems in identifying disease features, progression and treatment response for retinal diseases such as neovascular AMD and diabetic macular edema using optical coherence tomography (OCT). Additionally, the application of ML to visual fields may be useful in detecting glaucoma progression. There are limited studies that incorporate clinical data including electronic health records, in AL and DL algorithms, and no prospective studies to demonstrate that AI and DL algorithms can predict the development of clinical eye disease. This article describes global eye disease burden, unmet needs and common conditions of public health importance for which AI and DL systems may be applicable. Technical and clinical aspects to build a DL system to address those needs, and the potential challenges for clinical adoption are discussed. AI, ML and DL will likely play a crucial role in clinical ophthalmology practice, with implications for screening, diagnosis and follow up of the major causes of vision impairment in the setting of ageing populations globally.
引用
- Ting DSW, Peng L, Varadarajan AV, et al. Deep learning in ophthalmology: The technical and clinical considerations. Prog Retin Eye Res. 2019. PMID: 31048019. doi:10.1016/j.preteyeres.2019.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。